Report Detail
Global CAR T-Cell Therapy Market Growth (Status and Outlook) 2019-2024
- RnM3303154 |
- 11 April, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Other
Chimeric antigen receptor T cells (also known as CAR T cells) are T cells that have been genetically engineered to produce an artificial T-cell receptor. Chimeric antigen receptors (CARs, also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors) are receptor proteins that have been engineered to give T cells the new ability to target a specific protein. The receptors are chimeric because they combine both antigen-binding and T-cell activating functions into a single receptor. CAR-T cell therapy uses T cells engineered with CARs for cancer therapy. The premise of CAR-T immunotherapy is to modify T cells to recognize cancer cells in order to more effectively target and destroy them. Scientists harvest T cells from people, genetically alter them, then infuse the resulting CAR-T cells into patients to attack their tumors. CAR-T cells can be either derived from T cells in a patient's own blood (autologous) or derived from the T cells of another healthy donor (allogenic). Once isolated from a person, these T cells are genetically engineered to express a specific CAR, which programs them to target an antigen that is present on the surface of tumors. For safety, CAR-T cells are engineered to be specific to an antigen expressed on a tumor that is not expressed on healthy cells.
According to this study, over the next five years the CAR T-Cell Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in CAR T-Cell Therapy business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of CAR T-Cell Therapy market by product type, application, key companies and key regions.
This study considers the CAR T-Cell Therapy value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Allogeneic
Autologous
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Cancer Research Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Celgene (Juno Therapeutics)
Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global CAR T-Cell Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of CAR T-Cell Therapy market by identifying its various subsegments.
Focuses on the key global CAR T-Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the CAR T-Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of CAR T-Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global CAR T-Cell Therapy Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global CAR T-Cell Therapy Market Size 2014-2024
- 2.1.2 CAR T-Cell Therapy Market Size CAGR by Region
- 2.2 CAR T-Cell Therapy Segment by Type
- 2.2.1 Allogeneic
- 2.2.2 Autologous
- 2.3 CAR T-Cell Therapy Market Size by Type
- 2.3.1 Global CAR T-Cell Therapy Market Size Market Share by Type (2014-2019)
- 2.3.2 Global CAR T-Cell Therapy Market Size Growth Rate by Type (2014-2019)
- 2.4 CAR T-Cell Therapy Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Cancer Research Centers
- 2.4.3 Others
- 2.5 CAR T-Cell Therapy Market Size by Application
- 2.5.1 Global CAR T-Cell Therapy Market Size Market Share by Application (2014-2019)
- 2.5.2 Global CAR T-Cell Therapy Market Size Growth Rate by Application (2014-2019)
3 Global CAR T-Cell Therapy by Players
- 3.1 Global CAR T-Cell Therapy Market Size Market Share by Players
- 3.1.1 Global CAR T-Cell Therapy Market Size by Players (2017-2019)
- 3.1.2 Global CAR T-Cell Therapy Market Size Market Share by Players (2017-2019)
- 3.2 Global CAR T-Cell Therapy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 CAR T-Cell Therapy by Regions
- 4.1 CAR T-Cell Therapy Market Size by Regions
- 4.2 Americas CAR T-Cell Therapy Market Size Growth
- 4.3 APAC CAR T-Cell Therapy Market Size Growth
- 4.4 Europe CAR T-Cell Therapy Market Size Growth
- 4.5 Middle East & Africa CAR T-Cell Therapy Market Size Growth
5 Americas
- 5.1 Americas CAR T-Cell Therapy Market Size by Countries
- 5.2 Americas CAR T-Cell Therapy Market Size by Type
- 5.3 Americas CAR T-Cell Therapy Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC CAR T-Cell Therapy Market Size by Countries
- 6.2 APAC CAR T-Cell Therapy Market Size by Type
- 6.3 APAC CAR T-Cell Therapy Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe CAR T-Cell Therapy by Countries
- 7.2 Europe CAR T-Cell Therapy Market Size by Type
- 7.3 Europe CAR T-Cell Therapy Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa CAR T-Cell Therapy by Countries
- 8.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type
- 8.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global CAR T-Cell Therapy Market Forecast
- 10.1 Global CAR T-Cell Therapy Market Size Forecast (2019-2024)
- 10.2 Global CAR T-Cell Therapy Forecast by Regions
- 10.2.1 Global CAR T-Cell Therapy Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global CAR T-Cell Therapy Forecast by Type
- 10.8 Global CAR T-Cell Therapy Forecast by Application
11 Key Players Analysis
- 11.1 Celgene (Juno Therapeutics)
- 11.1.1 Company Details
- 11.1.2 CAR T-Cell Therapy Product Offered
- 11.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Celgene (Juno Therapeutics) News
- 11.2 Novartis
- 11.2.1 Company Details
- 11.2.2 CAR T-Cell Therapy Product Offered
- 11.2.3 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Novartis News
- 11.3 Gilead (Kite Pharma)
- 11.3.1 Company Details
- 11.3.2 CAR T-Cell Therapy Product Offered
- 11.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Gilead (Kite Pharma) News
- 11.4 Pfizer
- 11.4.1 Company Details
- 11.4.2 CAR T-Cell Therapy Product Offered
- 11.4.3 Pfizer CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Pfizer News
- 11.5 CARsgen Therapeutics
- 11.5.1 Company Details
- 11.5.2 CAR T-Cell Therapy Product Offered
- 11.5.3 CARsgen Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 CARsgen Therapeutics News
- 11.6 Autolus Therapeutics
- 11.6.1 Company Details
- 11.6.2 CAR T-Cell Therapy Product Offered
- 11.6.3 Autolus Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Autolus Therapeutics News
- 11.7 Aurora BioPharma
- 11.7.1 Company Details
- 11.7.2 CAR T-Cell Therapy Product Offered
- 11.7.3 Aurora BioPharma CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Aurora BioPharma News
- 11.8 Sorrento Therapeutics
- 11.8.1 Company Details
- 11.8.2 CAR T-Cell Therapy Product Offered
- 11.8.3 Sorrento Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Sorrento Therapeutics News
- 11.9 Mustang Bio
- 11.9.1 Company Details
- 11.9.2 CAR T-Cell Therapy Product Offered
- 11.9.3 Mustang Bio CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Mustang Bio News
- 11.10 Bluebird Bio
- 11.10.1 Company Details
- 11.10.2 CAR T-Cell Therapy Product Offered
- 11.10.3 Bluebird Bio CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Bluebird Bio News
- 11.11 Collectis
- 11.12 Allogene Therapeutics
- 11.13 Celyad
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on CAR T-Cell Therapy . Industry analysis & Market Report on CAR T-Cell Therapy is a syndicated market report, published as Global CAR T-Cell Therapy Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of CAR T-Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
